Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2 beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades
Markovic, Danijela, Punn, Anu, Lehnert, Hendrik and Grammatopoulos, Dimitris K.. (2008) Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2 beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. Molecular Endocrinology, Vol.22 (No.3). pp. 689-706. ISSN 0888-8809Full text not available from this repository.
Official URL: http://dx.doi.org/10.1210/me.2007-0136
Many important physiological roles of the urocortin (UCN) family of peptides as well as CRH involve the type 2 CRH receptor (CRH-R2) and downstream activation of multiple pathways. To characterize molecular determinants of CRH-R2 functional activity, we used HEK293 cells overexpressing recombinant CRH-R2 beta and investigated mechanisms involved in attenuation of CRH-R2 signaling activity and uncoupling from intracellular effectors. CRH-R2 beta-mediated adenylyl cyclase activation was sensitive to homologous desensitization induced by pretreatment with either UCN-II or the weaker agonist CRH. CRH-R2 beta activation induced transient beta-arrestin1 and beta-arrestin2, as well as clathrin, recruitment to the plasma membrane. beta-Arrestin2 appeared to be the main beta-arrestin subtype associated with the receptor. This was followed by CRH-R2 beta endocytosis in a mechanism that exhibited distinct agonist-dependent temporal characteristics. CRH-R2 beta also induced transient activation of the ERK1/2 and p38MAPK signaling cascades that peaked at 5 min and returned to basal within 20-30 min. Unlike p38MAPK, activated ERK1/2 was localized both in the cytoplasm and nucleus. Experiments employing inhibitors of receptor endocytosis showed that CRH-R2 beta-MAPK interaction does not require beta-arrestin, clathrin, or receptor endocytosis. Site-directed mutagenesis studies on CRH-R2 beta C terminus showed that the amino acid cassette TAAV at the end of the C terminus is important for CRH-R2 beta signaling because loss of a potential phospho-acceptor site in mutant receptors containing deletion or Ala substitution of the cassette TAAV resulted in reduced ERK1/2 activation and accelerated receptor internalization. These findings provide new insights about the signaling mechanisms regulating CRH-R2 beta functional activity and determining its biological responses.
|Item Type:||Journal Article|
|Subjects:||R Medicine > RC Internal medicine|
|Divisions:||Faculty of Science > Mathematics|
|Journal or Publication Title:||Molecular Endocrinology|
|Official Date:||March 2008|
|Number of Pages:||18|
|Page Range:||pp. 689-706|
|Access rights to Published version:||Restricted or Subscription Access|
Actions (login required)